2nd Quarter - Report

FOLEY HOAG LLP for MERCK

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Pharmaceutical coverage and reimbursement issues associated with American Recovery and Reinvestment Act of 2009

LobbyistCovered position, as disclosed
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S. 515, The Patent Reform Act

LobbyistCovered position, as disclosed
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 515 (111th)

Health Issues HCR

S. 1213, The Patient-Centered Outcomes Research Act H.R. 2502, The Comparative Effectiveness Research Act

LobbyistCovered position, as disclosed
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2502 (111th), S. 1213 (111th)

Medical/Disease Research/Clinical Labs MED

FDA Reform Bills

LobbyistCovered position, as disclosed
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.